Genetic Variation in the Indoleamine 2,3‐Dioxygenase Gene in Pre‐eclampsia

Citation Nishizawa H, Kato T, Ota S, Nishiyama S, Pryor‐Koishi K, Suzuki M, Tsutsumi M, Inagaki H, Kurahashi H, Udagawa Y. Genetic variation in the indoleamine 2,3‐Dioxygenase gene in pre‐eclampsia. Am J Reprod Immunol 2010; 64: 68–76

[1]  S. Mamidipalli,et al.  Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activity , 2009, Pharmacogenetics and genomics.

[2]  S. Yagel,et al.  Examination of distinct fetal and maternal molecular pathways suggests a mechanism for the development of preeclampsia. , 2007, Journal of reproductive immunology.

[3]  H. Kurahashi,et al.  Mouse model for allogeneic immune reaction against fetus recapitulates human pre‐eclampsia , 2007, The journal of obstetrics and gynaecology research.

[4]  H. Kurahashi,et al.  The Etiological Role of Allogeneic Fetal Rejection in Pre‐Eclampsia , 2007, American journal of reproductive immunology.

[5]  B. Peterlin,et al.  Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis. , 2007, European journal of obstetrics, gynecology, and reproductive biology.

[6]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[7]  K. Ohama,et al.  Mechanisms regulating the expression of indoleamine 2,3-dioxygenase during decidualization of human endometrium. , 2004, Human reproduction.

[8]  Johanna W Lampe,et al.  Antibiotic use in relation to the risk of breast cancer , 2004, JAMA.

[9]  F. Dudbridge.  Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[10]  J. Cross.  The genetics of pre‐eclampsia: a feto‐placental or maternal problem? , 2003, Clinical genetics.

[11]  I. Sargent,et al.  Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia. , 2003, American journal of obstetrics and gynecology.

[12]  H. Pearson.  Reproductive immunology: Immunity's pregnant pause , 2002, Nature.

[13]  G. Pals,et al.  Searching for preeclampsia genes: the current position. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[14]  Jm Roberts,et al.  Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.

[15]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[16]  D. Munn,et al.  Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? , 1999, Immunology today.

[17]  Y. Minatogawa,et al.  Gene structure of human indoleamine 2,3-dioxygenase. , 1992, Biochemical and biophysical research communications.

[18]  S. Gupta,et al.  Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha. , 1990, The Journal of biological chemistry.

[19]  D. Li,et al.  Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. , 2000, American journal of epidemiology.